Table 2.
Variable | Total (N = 47) |
---|---|
Size of implant (g), mean ± SD | 348.66 ± 86.54 |
(minimum–maximum) | (90.00–515.00) |
Missing, n (%) | 6 (12.8) |
LPF total (g), mean ± SD | 284.13 ± 62.94 |
(minimum–maximum) | (160.00–490.00) |
Contralateral operation, n (%) | |
No | 33 (70.2) |
Prosthesis removal | 7 (14.9) |
Mastopexy and breast reduction (<150 g) | 3 (6.4) |
Breast reduction (≥150 g) | 4 (8.5) |
Operative time (min) | |
General operative time, mean ± SD | 108.93 ± 17.65 |
(minimum–maximum) | (74.00–146.00) |
Missing, n (%) | 4 (8.5) |
No contralateral operation, mean ± SD | 104.07 ± 16.42 |
(minimum–maximum) | (74.00–145.00) |
Missing, n (%) | 3 (9.1) |
Contralateral operation prosthesis removal, mean ± SD | 114.71 ± 12.93 |
(minimum–maximum) | (95.00–138.00) |
Contralateral operation mastopexy or breast reduction (<150 g), md (IQR) | 111.50 (95.00–128.00) |
(minimum–maximum) | (95.00–128.00) |
Missing, n (%) | 1 (33.3) |
Contralateral operation breast reduction (≥150 g), mean ± SD | 134.00 ± 8.98 |
(minimum–maximum) | (125.00–146.00) |
%, relative frequency; IQR, interquartile range (percentiles 25th–75th); LPF, liposuctioned fat; md, median; n, absolute frequency; SD, standard deviation.